|
|
|
Insider
Information: |
Schoemaker Kathleen K |
Relationship: |
10% Owner |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
24 |
|
Direct
Shares |
8,715,548 |
|
Indirect Shares
|
3,038,103 |
|
|
Direct
Value |
$235,240,146 |
|
|
Indirect Value
|
$11,280,270 |
|
|
Total
Shares |
11,753,651 |
|
|
Total
Value |
$246,520,416 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-18 |
31,204 |
Premium* |
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-10 |
37,586 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
|
0 |
2009-01-30 |
67,875 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
29,887 |
2008-07-16 |
62,513 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
2014-02-12 |
2,972,678 |
2014-03-19 |
0 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
9,058 |
2011-12-22 |
50,643 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2014-01-16 |
3,590,931 |
2011-06-02 |
40,790 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2013-06-04 |
44,034 |
2011-11-21 |
51,013 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
Glaukos Corp |
GKOS |
10% Owner |
2015-06-30 |
2,068,960 |
2015-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
282 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-18 |
4 |
AS |
$5.16 |
$41,383 |
D/D |
(8,020) |
2,437,379 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-18 |
4 |
AS |
$5.16 |
$127,638 |
D/D |
(24,736) |
7,517,368 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-18 |
4 |
AS |
$5.16 |
$1,367 |
D/D |
(265) |
80,555 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-18 |
4 |
AS |
$5.16 |
$697 |
D/D |
(135) |
41,603 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-19 |
4 |
AS |
$5.19 |
$41,131 |
D/D |
(7,925) |
2,429,454 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-19 |
4 |
AS |
$5.19 |
$1,355 |
D/D |
(261) |
80,294 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-19 |
4 |
AS |
$5.19 |
$126,854 |
D/D |
(24,442) |
7,492,926 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-19 |
4 |
AS |
$5.19 |
$695 |
D/D |
(134) |
41,469 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-20 |
4 |
AS |
$5.22 |
$28,762 |
D/D |
(5,510) |
2,423,944 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-20 |
4 |
AS |
$5.22 |
$88,714 |
D/D |
(16,995) |
7,475,931 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-20 |
4 |
AS |
$5.22 |
$480 |
D/D |
(92) |
41,377 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-20 |
4 |
AS |
$5.22 |
$950 |
D/D |
(182) |
80,112 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-21 |
4 |
AS |
$5.49 |
$9,569 |
D/D |
(1,743) |
78,369 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-21 |
4 |
AS |
$5.49 |
$4,903 |
D/D |
(893) |
40,484 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-21 |
4 |
AS |
$5.35 |
$72,172 |
D/D |
(13,490) |
7,462,441 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-21 |
4 |
AS |
$5.35 |
$23,401 |
D/D |
(4,374) |
2,419,570 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-04-08 |
4 |
AS |
$6.52 |
$245,648 |
D/D |
(37,676) |
7,424,765 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-04-08 |
4 |
AS |
$6.52 |
$79,655 |
D/D |
(12,217) |
2,407,353 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-04-09 |
4 |
AS |
$6.71 |
$76,400 |
D/D |
(11,386) |
2,395,967 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-04-09 |
4 |
AS |
$6.71 |
$235,615 |
D/D |
(35,114) |
7,389,651 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-04-10 |
4 |
AS |
$6.72 |
$32,471 |
D/D |
(4,832) |
7,384,819 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-04-10 |
4 |
AS |
$6.72 |
$10,530 |
D/D |
(1,567) |
2,394,400 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-04-15 |
4 |
AS |
$6.62 |
$153,650 |
D/D |
(23,210) |
2,371,190 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-04-15 |
4 |
AS |
$6.62 |
$473,846 |
D/D |
(71,578) |
7,313,241 |
0 |
- |
|
ALIM |
Alimera Sciences Inc |
10% Owner |
|
2013-05-15 |
4 |
S |
$4.70 |
$107,940 |
D/D |
(22,966) |
4,106,807 |
0 |
- |
|
282 Records found
|
|
Page 9 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|